Entera Bio to Present Two Abstracts on its First-in-Class, Once Daily Oral hPTH(1-34) Peptide ...

JERUSALEM, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today announced

Related Keywords

Canada ,Jerusalem ,Israel General ,Israel ,Vancouver ,British Columbia ,United States ,Miranda Toledano ,Entera Bio Ltd ,Nasdaq ,Chief Executive Officer ,Teriparatide Tablets ,Post Menopausal Age Versus Young Adult ,Poster Session ,First Oral ,Tablet Treatment ,Plasma Levels ,Late Breaking Poster ,Late Breaking Poster Session ,Centera Bio ,Private Securities Litigation Reform Act ,Statements Regarding Forward Looking ,Financial Condition ,Annual Report ,Quarterly Reports ,Current Reports ,Region ,